EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Evaluation of the 2023 Duke-International Society of Cardiovascular Infectious Diseases Criteria in a Multicenter Cohort of Patients With Suspected Infective Endocarditis

Matthaios Papadimitriou-Olivgeris iD, Pierre Monney, Michelle Frank, Georgios Tzimas, Piergiorgio Tozzi, Matthias Kirsch, Mathias Van Hemelrijck, Robert Bauernschmitt, Jana Epprecht, Benoit Guery, Barbara Hasse

Clinical Infectious Diseases · 2024

DOI: 10.1093/cid/ciae039 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Matthaios Papadimitriou-Olivgeris und 10 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Endocarditis, Bacterial, Endocarditis, Heart Valve Prosthesis, Communicable Diseases. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, University of Zurich.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Since publication of Duke criteria for infective endocarditis (IE) diagnosis, several modifications have been proposed. We aimed to evaluate the diagnostic performance of the Duke-ISCVID (International Society of Cardiovascular Infectious Diseases) 2023 criteria compared to prior versions from 2000 (Duke-Li 2000) and 2015 (Duke-ESC [European Society for Cardiology] 2015).

Methods

This study was conducted at 2 university hospitals between 2014 and 2022 among patients with suspected IE. A case was classified as IE (final IE diagnosis) by the Endocarditis Team. Sensitivity for each version of the Duke criteria was calculated among patients with confirmed IE based on pathological, surgical, and microbiological data. Specificity for each version of the Duke criteria was calculated among patients with suspected IE for whom IE diagnosis was ruled out.

Results

In total, 2132 episodes with suspected IE were included, of which 1101 (52%) had final IE diagnosis. Definite IE by pathologic criteria was found in 285 (13%), 285 (13%), and 345 (16%) patients using the Duke-Li 2000, Duke-ESC 2015, or the Duke-ISCVID 2023 criteria, respectively. IE was excluded by histopathology in 25 (1%) patients. The Duke-ISCVID 2023 clinical criteria showed a higher sensitivity (84%) compared to previous versions (70%). However, specificity of the new clinical criteria was lower (60%) compared to previous versions (74%).

Conclusions

The Duke-ISCVID 2023 criteria led to an increase in sensitivity compared to previous versions. Further studies are needed to evaluate items that could increase sensitivity by reducing the number of IE patients misclassified as possible, but without having detrimental effect on specificity of Duke criteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endocarditis, BacterialEndocarditisHeart Valve ProsthesisCommunicable DiseasesHumansFluorodeoxyglucose F18

Stichwörter der Autor:innen

18F-FDG PET/CTDuke criteriaechocardiographyinfective endocarditisprosthetic valve

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Department of Cardiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Department of Cardiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Department of Cardiac Surgery, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Department of Cardiac Surgery, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

ORCID-Profile: Matthaios Papadimitriou-Olivgeris

Förderung

  • Swiss National Science Foundation
  • University of Zurich

Zitieren

APA

Papadimitriou-Olivgeris, M., Monney, P., Frank, M., Tzimas, G., Tozzi, P., Kirsch, M., Van Hemelrijck, M., Bauernschmitt, R., Epprecht, J., Guery, B., & Hasse, B. (2024). Evaluation of the 2023 Duke-International Society of Cardiovascular Infectious Diseases Criteria in a Multicenter Cohort of Patients With Suspected Infective Endocarditis. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae039

Vancouver

Papadimitriou-Olivgeris M, Monney P, Frank M, Tzimas G, Tozzi P, Kirsch M, et al. Evaluation of the 2023 Duke-International Society of Cardiovascular Infectious Diseases Criteria in a Multicenter Cohort of Patients With Suspected Infective Endocarditis. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciae039

BibTeX
@article{PapadimitriouOlivgeris2024,
  author = {Papadimitriou-Olivgeris, Matthaios and Monney, Pierre and Frank, Michelle and Tzimas, Georgios and Tozzi, Piergiorgio and Kirsch, Matthias and Van Hemelrijck, Mathias and Bauernschmitt, Robert and Epprecht, Jana and Guery, Benoit and Hasse, Barbara},
  title = {Evaluation of the 2023 Duke-International Society of Cardiovascular Infectious Diseases Criteria in a Multicenter Cohort of Patients With Suspected Infective Endocarditis},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  doi = {10.1093/cid/ciae039}
}
Kostenlos starten →